chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Expired vaccine used; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 18-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Blisters popping up; Patient was not breathing good and had to go to a pulmonary doctor; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (Blisters popping up) and DYSPNOEA (Patient was not breathing good and had to go to a pulmonary doctor) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037B21A and 017BZIA) for COVID-19 vaccination.     The patient had no allergies and no illness.  The patient had not ever tested or diagnosed COVID-19.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced BLISTER (Blisters popping up) and DYSPNOEA (Patient was not breathing good and had to go to a pulmonary doctor). At the time of the report, BLISTER (Blisters popping up) and DYSPNOEA (Patient was not breathing good and had to go to a pulmonary doctor) had not resolved. No Concomitant medications were reported. Patient stated he want to get to the bottom of this because patient still have side effects. patient had been to hospital twice. Treatment included antibiotics.   This case was linked to MOD-2022-585358 (Patient Link).
I began having shortness of breath two days after the booster; This spontaneous case was reported by an other health care professional and describes the occurrence of DYSPNOEA (I began having shortness of breath two days after the booster) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DYSPNOEA (I began having shortness of breath two days after the booster). At the time of the report, DYSPNOEA (I began having shortness of breath two days after the booster) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient had experienced shortness of breath after booster shot and it was over a month and patient had been struggling with the event.  No concomitant medications were reported  No treatment medications were reported
Pt had a very large red circle on her left deltoid.  She said it appeared a few hours after the immunization and it became larger and deeper purple over time.  She said there was a dull persistent pain and she felt a little nauseated.  Today is 9/20.  Three days have past.  She is feeling better but the erythema is still present (very large circle over her left deltoid).
patient came back 4/13/2021 the day the vaccine was paused due to thrombotic events concerned about her risk and health. She reported having body aches, sore throat, low grade fever, cough, and loss of appetite.
3 Spikevax syringes cracked during today's clinic while nurse was removing the cap. All belonged to Lot: 3031279. All 3 were recognized and discarded, not administered.
legs and feet did hurt; Muscle aches are not from flu like; This is a spontaneous report from a contactable nurse reporting for self. This (Age-44, unit-unknown) female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via unspecified route of administration on 08Jan2021 at single dose for COVID-19 immunisation. Medical history included fatigue, she felt fatigue every Friday. Concomitant medications were not reported. The patient stated she got her 2nd vaccine on 08Jan2021, stated "I haven't experienced any side effects, does that mean the vaccine isn't working? " Patient had little fatigue, and stated it's the same fatigue she felt every Friday baseline fatigue. Her legs and feet did hurt, but she had been walking from one end of the hospital to the other. Muscle aches were not from flu like. The outcome of events was unknown.    Information about Lot/batch number has been requested.
Recv'd flu shot on 11/3.Later that evening, pt dvlped stomach pains,diarrhea,dizziness,sweating,weakness,& headache. Woke up the next morning w/ cont'd headache & distorted vision. Saw retina specialist who dxed ischemic optic neuritis.
Initially jerking and progressing to rolling of the eyes, then whole body shaking. Currently hospitalized. Currently on phenobarbitol.
significant swelling and pain in left under arm; Pain in left under arm and moving into left pec; Tightness in surrounding muscles andinto bilateral upper traps; Pain in left under arm and moving into left pec; This is a spontaneous report from a contactable healthcare professional, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 30Mar2021 at 15:45 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included multivitamin (MANUFACTUER UNKNOWN), angelica polymorpha, atractylodes macrocephala, bupleurum falcatum, glycyrrhiza uralensis, mentha canadensis, paeonia lactiflora, poria cocos, zingiber officinale (XIAO YAO SAN) (herbal) and vitamin d nos (MANUFACTURER UNKNOWN), all for unknown indications from unknown dates.  The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 09Mar2021 at 15:45 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 31Mar2021 at 04:00, the patient experienced significant swelling and pain in left under arm, moving into left pec and tightness in surrounding muscles and into bilateral upper traps. The events resulted in the doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events significant swelling and pain in left under arm, moving into left pec and tightness in surrounding muscles and into bilateral upper traps. The clinical outcomes of the events swelling, armpit pain, muscle tightness and muscle pain were resolving at the time of the report.   No follow-up attempts are needed. No further information is expected.
Anaphylaxis, Benadryl 50mg, Sent to ED for further management
cont, inconsolable crying x 6hr;fever 101-102 x 6 days;irritability x 6 days;not seen by MD;
Twelve hours after shot, had shivering, fever, and heartbeat racing, lasted twelve hours.
I had no problems besides a sore arm after receiving the 1st dose. I see that my manufacturer is also different from my second dose. After receiving the 2nd dose I was totally exhausted couldn't do anything for 2 full months or about 8 or 9 weeks.
Immunized 10/17/08 at Health Fair after 1/2 she had rash on legs/arms/chest and lips swelled. No medical eval. Pt was a nurse who took BENADRYL every 6  Without further problems previously received flu shot without problem. Reports Increasing general hypersensitivity over the last few years.
Information has been received from a 67 year old retired female registered nurse with allergies to penicillin, cephalexin (KEFLEX) and a history of hysterectomy on 13-JUN-2003, who on Thursday, 22-MAR-2007 was vaccinated SC below the right deltoid with a dose of Zostavax. Concomitant therapy included lisinopril-HCTZ (MSD), estradiol (ESTRACE) 1 mg, atorvastatin calcium (LIPITOR) 10 mg and venlafaxine HCl (EFFEXOR XR) 150. On approximately 23-MAR-2007 (reported to be by Friday night or Saturday morning) the patient noticed about 3 pustules under the injection site, was feeling listless and some itching. The reporter stated that she was under a lot of stress at the time of vaccination due to the loss of her sister in December. The patient stated that this may have made her immune system low. At the time of the report medical attention had been sought though the patient confirmed that she would follow up with her physician. At the time of the report the patient had not recovered. There was no product quality complaint involved. No further information is available.
pt recv vax 5JAN98 & devel inj site pain, fatigue, greater frequency of migraines, vorse vision, & tingling that has cont for 6months;
Patient was given a dose of Kinrex (combination of Dtap and Polio) and a separate dose of Polio.  Vaccine staff thought Kinrex vaccine contained only Dtap.  Patient received 2 doses of Polio vaccine. No reaction observed or reported.
pt recv vax pt exp fatigue;had low grade temp, WBC was up;sed rate messed up;dx lupus;rt knee swollen, disorientated;weakened;?depression,immune system messed up;lupus d/t chronic fatigue;
This spontaneous report was received from a pharmacist refers to a 80 years old male patient. The patient was vaccinated subcutaneously with 0.65 ml dose of ZOSTAVAX lot # (670980/0731AA), on 13-JUL-2012, which was reconstituted with expired diluents (Lot#G000186, exp: March 2012). There was no relevant laboratory data. The patient had not experienced any side effects after he had received ZOSTAVAX with an expired diluents. Additional information has been requested.
This spontaneous report as received from a Nurse Practitioner concerning a 2 year old male patient with snoring and no drug allergies or reactions who on 08-APR-2013 was vaccinated with a dose of M-M-R II (dose and route not provided) (lot # H014680). Concomitant therapies included VERAMYST. On 14-APR-2013, the patient developed fever as high as 103 degrees F. The nurse described that when he was seen in the office he had lymphadenopathy on the right side and a temperature of 102.2, the right tonsil was more swollen than the left tonsil. When seen in the office on 16-APR-2013, the right tonsil had improved but he had left side edema in his lymph nodes. AUGMENTIN was given as a treatment for the events. The outcome of lymphadenopathy on the right site was reported as not recovered/not resolved. Additional information has been requested.
Numbness [and tingling] of extremities; Inability to lift the arm past their shoulder; Tingling in extremities; This is a spontaneous case initially received from other health professional (nurse) on 26-Oct-2018, concerning a female patient of an unspecified age.  On an unspecified date in Sep-2018, the patient was administered Afluria Quadrivalent (influenza vaccine, dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch number: YF39107 and expiry date: 30-Jun-2019) for influenza prophylaxis.  On the same day after vaccination, the patient was unable to lift the arm past her shoulder and experienced numbness and tingling in her extremities.  The outcome of the events was recovered (2 weeks or more after administration date).  The reporter assessed the case as non-serious.; Reporter's Comments: A female patient of an unspecified age experienced numbness and tingling in her extremities and was unable to lift her arm past shoulder, on the same day after the administration of Afluria Quadrivalent. The company assessed the causality as related due to plausible temporal relationship between the events and the suspect vaccine.
Moderna COVID-19 Vaccine EUA Very anxious prior to receiving first dose of Moderna Covid Vaccine. One hour after receiving vaccine complaint of itchy hands and felt as if "ants were crawling all over her". She said has an allergy to Latex and was previously wearing Lavender Nitrile gloves. No hives or erythema on exam, some mild erythema to area after scratching hands with nails, no raised wheals.  Sensation of pruritis spread to back and neck without urticaria. Diphenhydramine 50mg was administered. Approximately 30 minutes patient complained of nausea and was give Ondansetron 4mg which alleviated nausea. Pruritis resolved but approx 30 min patient began to feel tired, dizzy and lightheaded. Vitals were taken and orthostatic blood pressures were performed. All vitals were normal, oxygen saturation was normal and injection site was without erythema and no evidence of urticaria. Physical exam was also performed and no abnormalities to heart or lungs were auscultated.
Stomachache, headache, fatigue, low grade fever. 300mg ibuprofen every 8hrs. Headache, fatigue, and low grade fever has passed. Stomachache persists.
Was given IZ on 9/12/00 and noticed on 9/13/00 in the afternoon, a red, warm area. On 9/14/00, it increased in size and warmth. Seen in office, instructed to use cool compress and Tylenol and come back in 1-2 weeks for recheck, unless needs to be seen sooner.
This spontaneous report as received from a other health professional refers to a patient of unknown age. On 29-AUG-2017 the patient was vaccinated with VAQTA lot # N012324 for prophylaxis. Other suspect therapies included ROTATEQ, PEDVAXHIB and M-M-R II (rHA). Concomitant therapies included sterile diluent. On 29-AUG-2017, 1 day after onset of therapy the patient experienced incorrect product storage. On an unknown date the patient experienced no adverse event. The outcome of incorrect product storage and no adverse event is unknown. The reporter considered incorrect product storage to be not related to M-M-R II, ROTATEQ, PEDVAXHIB and VAQTA. The reporter considered no adverse event to be not related to ROTATEQ, M-M-R II, PEDVAXHIB and VAQTA. Sender's Comments: US-009507513-1708USA012838: US-009507513-1708USA013542: US-009507513-1708USA013545: US-009507513-1708USA013546: US-009507513-1708USA013547: US-009507513-1708USA013548: US-009507513-1708USA013549: US-009507513-1708USA013551: US-009507513-1708USA013552: US-009507513-1708USA013538: US-009507513-1708USA013539: US-009507513-1708USA013537: US-009507513-1708USA013540: US-009507513-1708USA013541: US-009507513-1708USA013543: US-009507513-1708USA013544.
Runny nose; Headache; Chills; 1.5 Fever Temperature for 3 days; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine and experienced Headache, chills, runny nose and 1.5 fever temperature for 3 days.  The patient's medical history high blood pressure. Concomitant medication was High blood pressure medication (Name Unknown).   On 24 Dec 2020 prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 025J20-2A) intramuscularly for prophylaxis of COVID-19 infection.   After receiving the vaccine, the patient experienced headache, chills, runny nose and 1.5 fever for 3 days. Treatment was Unknown.  Action taken with the second dose of mRNA-1273 in response to the event was not reported.   The outcome for the events were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
PATIENT HAD TO GO TO EMERGENCY BECAUSE SHE HAD HIVES AND DIFFICULTY OF BREATHING ABOUT ONE HOUR AFTER RECEIVING THE IMMUNIZATION. SHE RETURNED TO THE PHARMACY TODAY AND TOLD US WHAT HAPPENED. SHE WAS PRESCRIBED PREDNISONE, EPI-PEN AND BENADRYL
collapses and Died; Initial information received on 27-Jan-2022 regarding an unsolicited valid Social Media serious case received from a consumer/non-hcp.  This case involves a 16 years old male patient who collapses and died while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site.  On an unknown date the patient collapses and died (death) (unknown latency) following the administration of INFLUENZA VACCINE. This event was assessed as medically significant and was leading to death.  Final diagnosis was (fatal) collapses and died.  Action taken  was not applicable.  It was not reported if the patient received a corrective treatment for the event (collapses and Died).  At time of reporting, the outcome was Fatal for the event collapses and died. No autopsy was done. The cause of death was reported as Unknown cause of death.; Reported Cause(s) of Death: Unknown
Rash, treated with cold compress History of COVID-19 in Jan 2021, so could have take an immunologic rash opposed to allergic rash
On 7-11-15 noticed a half dollar sized welt on arm that received vaccine. Has since grown to most of upper forearm. Warm to touch and itching is evident.
Pain and soreness in my arm; Pain and soreness in my shoulder; impossible to use that arm for routine tasks, such as dressing or brushing hairs; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 66-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pain (1st dose received on an unknown date, for tolerance refer linked case US2020AMR050143).   On 20th February 2020, the patient received the 2nd dose of Shingrix. On 20th February 2020, immediately after receiving Shingrix, the patient experienced pain in arm, shoulder pain and activities of daily living impaired. On an unknown date, the outcome of the pain in arm, shoulder pain and activities of daily living impaired were unknown.   It was unknown if the reporter considered the pain in arm, shoulder pain and activities of daily living impaired to be related to Shingrix.  Additional details were provided as follows: The patient had pain and soreness in arm and shoulder since receiving vaccine. The 2nd dose had made it impossible, at times, to use that arm for routine tasks, such as dressing or brushing hair. The patient asked what would cause this, and what can he/she do to stop the pain.
No difficulty breathing. No shortness of breath. Pt reported gums sore and swollen. Saw Primary Care physician. Treated with BENADRYL PO, MAALOX Mouth Wash. PCP Dx r/o allergy to nuts. (Pt ate nuts prior to mouth swelling).
SkinRash, CoughWheeze, HYPERtension, sensation of throat thickness Narrative: in the first 15 minutes after receiving the 2nd vaccine at 9am felt thickness on the left side of throat and feeling of pressure in chest then coughing was RRT called went to ED elevated BP symptoms dissipated was DCed at 3 pm developed sensation of "sun burn on chest and back felt hot to the touch
Autoimmune panel came back as positive; Chronic headache (daily head pressure and pain); This spontaneous case was reported by a consumer and describes the occurrence of PANEL-REACTIVE ANTIBODY (Autoimmune panel came back as positive) and HEADACHE (Chronic headache (daily head pressure and pain)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PANEL-REACTIVE ANTIBODY (Autoimmune panel came back as positive) and HEADACHE (Chronic headache (daily head pressure and pain)). At the time of the report, PANEL-REACTIVE ANTIBODY (Autoimmune panel came back as positive) and HEADACHE (Chronic headache (daily head pressure and pain)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details not reported by the reporter.   This case was linked to MOD21-078107, MOD-2021-015967, INC.-MOD-2021-080106 (E2B Linked Report).; Sender's Comments:  MOD21-078107: MOD-2021-015967:MOD21-033662INC.-MOD-2021-080106:MOD21-078196
mom states pt began raised, red, rash all over trunk, arms, legs w/swollen hands & feet minimal fever; no dyspnea or SOB reported; no localized reaction @ the site noted by mom;;
This spontaneous report was received from a pharmacist via company representative concerning a 65 year old male patient. Information on the patient's concomitant medications, pertinent medical history and drug reactions or allergies was unknown. On 26-AUG-2018, the patient was vaccinated with a dose of PNEUMOVAX 23 for prophylaxis at a pharmacy (dosing details, lot#, expiry date not reported). It was unknown by the reporter if the patient had received PNEUMOVAX 23 previously. On an unknown date in August 2018, the patient experienced redness and swelling at the injection site (vaccination site swelling and vaccination site erythema). On 27-AUG-2018, the patient went to the pharmacy due to the events. The patient was not given treatment for his symptoms; however, the pharmacist advised the patient to start taking TYLENOL for the symptoms. The pharmacist also advised the patient that if the symptoms continue or worsen, to seek medical attention with a physician. No product quality was involved. Outcome of vaccination site swelling and vaccination site erythema was unknown. The reporter's causality assessment was not provided.
Patient is a 11 year old male who was given Dtap instead of Tdap. The incident occurred 4/12/2022 but was barely discovered 4/27/2022 because the patient came back for more vaccines. When he came mom did not mention of any side effects or conditions he might have developed throughout the days that followed.
This case was received from a consumer on 11 February 2010, via an article. A 4-year-old preschool student was diagnosed with pertussis; it was reported that the child was "up-to-date with four DTap vaccinations". No additional information was reported.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose01/8/21 2nd dose01/29/21 Diagnosed covid positive:08/16/21 Symptom onset:08/15/21 Exposure:community Symptoms: fatigue,loss of smell/taste, runny nose,HA, cough, sorethroat, muscle aches